This page provides educational resources, events, news and products related to liquid biopsies. Content will cover aspects from advances in early cancer diagnosis and response to treatment, to their use alongside traditional biopsy techniques.
Liquid Biopsies – Highlights
Circulating Tumor Cells: Detection and Applications
In this article we explore circulating tumor cells (CTCs) asking what they are, why they are so valuable and how they are being used in modern oncology.
Liquid Biopsy: Reading the Signs of Disease From Biofluid
Liquid biopsy is a novel diagnostic tool, which seeks for signs of disease from various biofluids. This article will explore recent developments in the liquid biopsy field and the impact they are making on patients.
Applications of Liquid Biopsy in Cancer and Beyond
Liquid biopsies are becoming an increasingly important tool for the early detection, prognosis and monitoring of treatment outcomes in cancer, and hold the promise of transforming the management of other diseases in the future.
Liquid Biopsy: Guide, Applications and Techniques
Liquid biopsies are tests conducted on blood samples that examine biomarkers shed by tumors, such as cancer cells or pieces of tumor DNA. The data from liquid biopsies can be used in place of or alongside that of traditional surgical biopsies. In this article, we review the theory behind liquid biopsies and their applications in cancer medicine.
Simple Urine Test Predicts Bladder Cancer Years Before Diagnosis
Researchers have identified 10 genetic mutations that can predict the most common type of bladder cancer up to 12 years prior to diagnosis. The study results were presented at the European Association of Urology (EAU) annual Congress in Milan.
“Dead Zone” Within Tumors Helps Cancers Spread
New research has highlighted the role of a tumor's necrotic core in promoting metastasis, linking necrosis, circulating tumor cells and metastasis.
Liquid Biopsy Test: Protocol and Steps
In this article, we explore some of the advanced molecular techniques that are most used for detecting the main biomarkers involved in liquid biopsy.
What Is a Liquid Biopsy?
In this article, we explore the basics behind liquid biopsy, a test that has revolutionized diagnostics for cancer and other conditions.
Personalis Selected for Clinical Research After Successful Evaluation of Residual Disease Assay
Personalis, Inc. has announced it will continue its collaboration with AstraZeneca to explore ultra-sensitive molecular residual disease measurement, including clinically relevant and personalized variant tracking, for clinical research and drug development.
Beckman Coulter Life Sciences Presenting at SLAS2023
Beckman Coulter Life Sciences will have a full team of dedicated professionals and informative programming at the upcoming Society for Laboratory Automation and Screening International Conference and Exhibition.